Heron Therapeutics HRTX
NASDAQ HRTX
$0.29 -0.05 (-14.34%)
As of: Oct 22, 2026 · 3:58 PM EDT

Heron Therapeutics (HRTX) Long-Term Debt Issuances (2011 - 2025)

Updated

Heron Therapeutics (HRTX) posted Long-Term Debt Issuances of -$36.66 million for Q4 2025.

Analysis

Heron Therapeutics (HRTX) Long-Term Debt Issuances (2011 - 2025) Analysis & Trends

For FY2025, Heron Therapeutics' Long-Term Debt Issuances came in at $105.38 million.

  • Annual Long-Term Debt Issuances shows a four-year compound annual growth rate of -8.3% (FY2021 to FY2025).
  • In prior years, Heron Therapeutics' Long-Term Debt Issuances was $24.35 million in FY2023 and $148.96 million in FY2021.
  • The Q4 2025 figure stands as the highest quarterly Long-Term Debt Issuances since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Heron Therapeutics 55.27 Mn -134.29 Mn 26.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.79 Mn
Sep 30, 2021 -19,000.00
Dec 31, 2011 -188,000.00
API Access

Heron Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=HRTX&period=max&api_key=YOUR_API_KEY